Chemical Properties:
Package: Bottle, Aluminum foil bag, 25kg/Cardboard drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer Supply with High Purity and Stable Quality Chemical Name: Abacavir Sulfate CAS: 188062-50-2 A powerful nucleoside reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS API High Quality, Commercial ProductionItem | Specifications |
Appearance | White to Off-White Crystalline Powder |
Identification | (1) IR Spectrum (2) HPLC (3) Sulfate |
Melting Point | >205℃ (dec.) |
Residue on Ignition | ≤0.20% |
Heavy Metals | ≤20ppm |
Water (USP Method) | ≤1.0% |
Related Substances | |
Descyclopropyl Abacavir | ≤0.10% |
Dihydro Abacavir | ≤0.10% |
Abacavir Penultimate | ≤0.10% |
O-Pyrimidinyl Abacavir | ≤0.15% |
Any Unspecific Impurity | ≤0.10% |
Total Impurities | ≤0.50% |
Stereoisomer | ≤0.20% |
Content of Sulfate | 13.6%~15.0% |
Residual Solvents | |
Methanol | ≤0.50% |
Acetone | ≤0.50% |
Ethanol | ≤0.50% |
Assay | 98.0%~102.0% (calculated on anhydrous and solvent free basis) |
Test Standard | United States Pharmacopeia (USP) Standard |
Usage | API; anti-HIV |
Description:
Specifications:
Package & Storage:
Chemical Name | Abacavir Sulfate |
CAS Number | 188062-50-2 |
CAT Number | RF-API63 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C28H38N12O6S |
Molecular Weight | 670.74 |
Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Abacavir Sulfate (CAS 188062-50-2) is a nucleoside reverse transcriptase inhibitor that works against replication of a variety of HIV-1 and HIV-2 strains, inhibits HIV replication. Antiretroviral agent. Abacavir Sulfate was first launched as Ziagen in the US for the treatment of human immunodeficiency virus (HIV) infection, in combination with other antiretroviral drugs. Abacavir is a carbocyclic nucleoside reverse transcriptase inhibitor (nRTI); it is one of the most potent anti-HIV agents to date. In clinical trials for HIV infections in adults, it produced durable suppression in viral load.